Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tryngolza
Podcast
A pivotal time for an RNA pioneer
Ionis Pharmaceuticals is entering a busy stretch, with an FDA decision ahead and key phase 3 data expected this year.
Angus Liu
,
Ayla Ellison
May 1, 2026 8:30am
Ionis slashes Tryngolza's price ahead of planned label expansion
Mar 25, 2026 2:59pm
Ionis doubles its sales projection for Tryngolza in sHTG to $2B
Jan 13, 2026 3:45pm
Arrowhead strikes true with first FDA approval
Nov 18, 2025 3:44pm
Ionis' Tryngolza win in sHTG sends shares soaring by 27%
Sep 2, 2025 11:30am
Ionis chalks up phase 3 trial win as it works to grow Tryngolza
May 19, 2025 12:10pm
